Cassie Jung
Chief Operating Officer · Aquestive Therapeutics, Inc.
- 2024
- Sep 8, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Cassie Jung files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Barber - $1.22M in AQST purchases and sales in the last 12 months
- A. Ernest Toth Jr. - $243K in AQST purchases and sales in the last 12 months
- Lori J. Braender - $167K in AQST purchases and sales in the last 12 months
- Julie Krop - $125K in AQST purchases and sales in the last 12 months
- Peter E. Boyd - $124K in AQST purchases and sales in the last 12 months
- Sherry Korczynski - $111K in AQST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Cassie Jung?
Cassie Jung is a corporate insider, tracked as Chief Operating Officer of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Cassie Jung submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Cassie Jung been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($976K) across all tracked filings.
